Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04217733
PHASE3
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
Sponsor: Tanta University
View on ClinicalTrials.gov
Summary
Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome
Official title: A Comparative Study to Assess Safety and Effectiveness of Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2019-11-01
Completion Date
2030-12-30
Last Updated
2020-01-03
Healthy Volunteers
No
Conditions
Interventions
DRUG
pentoxyifylline
Pentoxyifylline two times daily for 3 months
DRUG
Mebeverine
Mebeverine 3 times for 3 months
DRUG
ethosuximide
ethosuximide 3 times for 3 months
Locations (1)
Sherief Abd-Elsalam
Tanta, Egypt